Clinical Validation:

Multiple prospective clinical trials involving a total of over 3,000 subjects have clearly demonstrated the prediabetes and type 2 diabetes screening accuracy of SCOUT DS. To find out more, click on the links below.

• Clinical Results Summary
• Clinical Dossier
• Publications

SCOUT DS uses visible light to noninvasively measure changes in a person's skin indicative of prediabetes and type 2 diabetes, enabling cost-effective, opportunistic screening of those at risk.

No blood - No fasting - No waiting.

• SCOUT Demonstration Video
• SCOUT Quick Start Guide
• SCOUT Brochure

The SCOUT DS is now available in the following regions:

• North America
• Europe
• Middle East/Africa
• Asia pacific
• South America
more...